Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cartesian Therapeutics (NASDAQ: RNAC) said management will participate in investor conferences in March and April 2026, including a presentation at the 46th Annual TD Cowen Health Care Conference and fireside chats at Leerink and Needham.

Live webcasts and archived replays will be accessible in the Events section of the company website for a limited time.

News Market Reaction – RNAC

+0.72% 2.3x vol

7 alerts

+0.72% News Effect

+4.4% Peak in 2 hr 10 min

+$1M Valuation Impact

$202M Market Cap

2.3x Rel. Volume

On the day this news was published, RNAC gained 0.72%, reflecting a mild positive market reaction. Argus tracked a peak move of +4.4% during that session. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $1M to the company's valuation, bringing the market cap to $202M at that time. Trading volume was elevated at 2.3x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

FREDERICK, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in March and April:

• A presentation at the 46^th Annual TD Cowen Health Care Conference at 11:50 a.m. ET Monday, March 2, 2026
• A fireside chat at Leerink’s Global Healthcare Conference at 10:00 a.m. ET on Monday, March 9, 2026
• A fireside chat at the 25^th Annual Needham Virtual Healthcare Conference at 9:30 a.m. ET on Monday, April 13, 2026
  

Live webcasts of the fireside chats and presentation are expected to be accessible in the Events section of the Company’s website at www.cartesiantherapeutics.com, where an archived replay of the events will also be available for a limited time.

About Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis with plans to initiate a Phase 2 trial in myositis. For more information, please visit www.cartesiantherapeutics.com or follow the Company on LinkedIn or X.

Investor Contact

Megan LeDuc
Associate Director, Investor Relations
megan.leduc@cartesiantx.com

Media Contact

David Rosen
Argot Partners
david.rosen@argotpartners.com

FAQ

When will Cartesian Therapeutics (RNAC) present at the TD Cowen Health Care Conference in 2026?

Cartesian will present at 11:50 a.m. ET on Monday, March 2, 2026. According to Cartesian Therapeutics, the presentation is part of their investor conference schedule and will be webcast via the Events section of the company website.

How can investors watch Cartesian Therapeutics (RNAC) fireside chats in March and April 2026?

Investors can watch via live webcast and archived replay on the company website Events page. According to Cartesian Therapeutics, webcasts for the Leerink and Needham sessions will be available and replayed for a limited time.

What time is the Cartesian Therapeutics (RNAC) fireside chat at Leerink’s Global Healthcare Conference?

The Leerink fireside chat is scheduled for 10:00 a.m. ET on Monday, March 9, 2026. According to Cartesian Therapeutics, management will appear live and a replay will be posted in the Events section of the company website.

When is Cartesian Therapeutics (RNAC) scheduled to speak at the Needham Virtual Healthcare Conference?

Cartesian is scheduled for a fireside chat at 9:30 a.m. ET on Monday, April 13, 2026. According to Cartesian Therapeutics, the session will be webcast and an archived replay will be available on the Events page for a limited time.

Where will archived replays of Cartesian Therapeutics (RNAC) conference presentations be available?

Archived replays will be posted on the company Events section of www.cartesiantherapeutics.com for a limited time. According to Cartesian Therapeutics, live webcasts and subsequent replay access will be provided there for investor viewing.